13
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Can Glucosamine Be Used in Patients with Diabetes Mellitus?

(Professor of Pharmacy Practice, Director of Compiemen)
Pages 101-112 | Published online: 20 Aug 2009

References

  • Anonymous. Prev a lence Sta tis tics. Amer i can Col lege of Rheumatology March 21, 2001, http://www.rheumatology.org/press/index.asp
  • Felson D T, Zhang Y. An up date on the ep i de mi ol ogy of knee and hip osteo -arthritis with a view to pre ven tion. Ar thri tis Rheum 1998; 41: 1343–1355
  • Felson D T, Lawrence R C, Dleppe P A, Hirsch R, Helmick C G. NIH con fer ence. Osteoarthritis: New in sights. Part 1: The dis ease and its risk fac tors. Osteoarthritis: The dis ease and its prev a lence and im pact. Ann In tern Med 2001; 133(8)635–646
  • Hand book of Pathophysiology, H N Holmes. Spring -house Corp, Springhouse, PA 2001
  • Dowdy P A, Cole B J, Harner C D. The phy si cian and sportsmedicine knee ar thri tis in ac tive in di vid u als: Matching treat ment to the di ag no sis. March 21, 2001, http://www.physsportsmed.com
  • Jordan J M, Kington R S, Lane N E, Nevitt M C, Zhang Y, Sowers M, McAlindon T, Spector T D, Poole A R. NIH con fer ence. Osteoarthritis: New in sights. Part 1: The dis ease and its risk fac tors. Osteoarthritis: Sys temic risk fac tors for osteoarthritis. Ann In tern Med 2001; 133(8)635–646
  • McCance K L, Huether S E. Pathophysiology. The Bi o logic Ba sis for Dis ease in Adults and Children. Mosby, St. Louis, MO 1998
  • Rehman Q, Lane N E. Getting con trol of osteoarthritis: An up date on treat ment op tions. Postgrad Med 1999; 106(4)127–134
  • Felson D T, Lawrence R C, Hochberg M C, McAlindon T, Dieppe P A, Minor M A, Blair S N, Berman B M, Fries J F, Weinberger M, Lorig K R, Jacobs J J, Goldberg V. Osteoarthritis: New In sights. Part 2: Treat ment ap proaches. Ann In tern Med 2000; 133(9)726–737
  • Altman R D, Hochberg M C, Moskowitz R W, Schnitzer T J. Rec om men da tions for the med i cal man age ment of osteoarthritis of the hip and knee. Ar thri tis Rheum 2000; 43(9)1905–1915
  • Shield M J. Anti-in flam ma tory drugs and their ef fects on car ti lage syn the sis and re nal func tion. Eur J Rheumatol Inflamm. 1993; 13(1)7–16
  • Rao J K, Mihaliak K, Kroenke K, Bradley J, Tierney W M, Weinberger M. Use of com ple men tary ther a pies for ar thri tis among pa tients of rheumatologist. Ann In tern Med 1999; 131: 409–416
  • Abdel Fattah W, Hammad T. Chondroitin sul fate and glucosamine: A re view of their safety pro file. JANA 2001; 3(4)17–24
  • da Camara C C, Dowless G V. Glucosamine sul fate for osteoarthritis. Ann Pharmacother 1998; 32(5)580–587
  • Chavez M L. Glucosamine sul fate and chondroitin sul fates. Hosp Pharm 1997; 32(9)1275–1285
  • De los Reyes G C, Koda R T, Lien E J. Glucosamine and chondroitin sul fates in the treat ment of osteoarthritis: A sur vey. Prog Drug Res 2000; 55: 81–103
  • Anon y mous. Glucosamine. The Re view of Nat u ral Prod ucts. Facts and Com par i sons, St. Louis, MO Nov, 1996
  • Deal C L, Moskowitz R W. Nutraceuticals as ther a peu tic agents in osteoarthritis. The role of glucosamine, chondroitin sul fate, and col la gen hydrolysate. Rheum Dis Clin North Amer 1999; 25(2)379–395
  • Setnikar I, Palumbo R, Canali S, Zanolo G. Pharmacokinetics of glucosamine in man. Arzneimittelforschung 1993; 43(10)1109–1113
  • McAlindon T E, LaValley M P, Gulin J P, Felson D T. Glucosamine and chon -droitin for treat ment of osteoarthritis. A sys tem atic qual ity as sess ment and meta-anal y-sis. JAMA 2000; 283: 1469–1473
  • Towheed T E, Anastassiades T P, Shea B, Houpt J, Welch V, Hochberg M C. Glucosamine ther apy for treat ing osteoarthritis (Cochrane Re view). The Cochrane Li brary. Update Soft ware, Oxford 2001; 1
  • Reginster J Y, Deroisy R, Rovati L C, Lee R L, Lejeune E, Bruyere O, Giacovelli Henrotin Y, Dacre J E, Gossett C. Long-term ef fects of glucosamine sul phate on osteoarthritis pro gres sion: A ran dom ised, pla cebo-con trolled clin i cal trial. Lan cet 2001; 357: 251–256
  • Kang J, Heart E, Sung C K. Ef fects of cel lu lar ATP de ple tion on glu cose transport and in su lin sig nal ing in 3T3-L1 adipocytes. AJP-En do crine Metab 2001; 280(3)E428–E435
  • Fenton J I, Chlebek-Brown K A, Peters T L, Caron J P, Orth M W. Glucosamine HCl re duces equine ar tic u lar car ti lage deg ra da tion in explant cul ture. Osteoarthritis Car ti lage 2000; 8: 258–265
  • Kelley D E. Over view: What is in su lin re sis tance?. Nutr Rev 2000; 58(3)S2–S3, Pt2
  • Nelson B A, Robinson K A, Buse M G. High glu cose and glucosamine in duce insulin resistance via different mechanisms in 3T30L1 adipocytes. Diabetes 2000; 49(6)981–991
  • Miles P DG, Higo K, Olefsky J M. Ex er cise-stim u lated glu cose turn over in the rat is im paired by glucosamine in fu sion. Di a be tes 2001; 50: 139–142
  • Heart E, Choi W S, Sung C K. Glucosamine-in duced in su lin re sis tance in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2000; 278: E103–E112
  • Reaven G M. Role of in su lin re sis tance in hu man dis ease (syn drome X): An expanded def i ni tion. Ann Rev Med 1993; 44: 121–131
  • Monauni T, Zenti M GG, Cretti A, Daniels M C, Targher G, Caruso B, Caputo M, McClain D, Del Prato S, Giaccari Muggeo M, Bonora E, Bondadonna R C. Ef fects of glucosamine in fu sion on in su lin se cre tion and in su lin ac tion in hu mans. Di a be tes 2000; 49: 926–935
  • Hawkins M, Hu M, Yu J, Eder H, Vuguin P, She L, Barzilai N, Leiser M, Backer J M, Rossetti L. Dis cor dant ef fects of glucosamine on in su lin-stim u lated glu cose me-tab o lism and phosphatidylinositol 3-kinase ac tiv ity. J Biol Chem 1999; 274(44)31312–31319
  • Balkan B, Dunning B E. Glucosamine in hib its glucokinase in vi tro and pro duces a glu cose-spe cific im pair ment of in vivo in su lin se cre tion in rats. Di a be tes 1994; 43: 1173–1179
  • Patti M E, Virkamaki A N, Landaker E J, Kahn C R, Yki-Jarvinen H. Ac ti va tion of the hexosamine path way by glucosamine in vivo in duces in su lin re sis tance of early postreceptor in su lin sig nal ing events in skel e tal mus cle. Di a be tes 1999; 48: 1562–1571
  • Virkamaki A, Daniels M C, Hamalainen S, Utriainen T, McCain D, Yki-Jarvinen H. Ac ti va tion of the hexosamine path way by glucosamine in vivo in duces in su- lin re sis tance in mul ti ple in su lin sen si tive tis sues. Endocrinol 1997; 138(6)2501–2507
  • Ross S A, Chen X, Hope H R, Sun S, McMahon E G, Roschat K, Gulve E A. De-vel op ment and com par i son of two 3T3-L1 adipocyte mod els of in su lin re sis tance: increased glu cose flux vs. glucosamine treat ment. Biochem Biophys Res Comm 2000; 273: 1033–1041
  • Balkan B, Dunning B E. Glucosamine in hib its glucokinase in vi tro and pro duces a glu cose-spe cific im pair ment of in vivo se cre tion in rats. Di a be tes 1994; 43: 1173–1179
  • Monauni T, Zenti M G, Cretti A, Daniels M C, Targher G, Caruso B, Caputo M, McCain D, Del Prato S, Giaccari A, Muggeo M, Bonora E, Bonadonna R C. Ef fects of glucosamine in fu sion on in su lin se cre tion and in su lin ac tion in hu mans. Di a be tes 2000; 49: 926–935
  • Almada A L, Harvey P W, Platts K H. Ef fects of chronic oral glucosamine sul fate on fast ing in su lin re sis tance in dex (FIRI) in nondiabetic in di vid u als. FASEB 2000; 14(4)A750
  • Tapadinhas M J, Rivera I C, Bignamini A A. Oral glucosamine sul fate in the man age ment of arthrosis: Re port on a multi-cen tre open in ves ti ga tion in Por tu gal. Pharmatherapeutica 1982; 3: 157–168
  • Anon y mous. Glucosamine/chondroitin ar thri tis in ter ven tion trial. Na tional Center for Com ple men tary and Al ter na tive Med i cine (NCCAM). March 21, 2001, http://www.clinicaltrials.gov

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.